Blog: The Myriad gene patent case: its potential impact on the...
Aug 1, 2012 | Posted by: roboblogger | Full story: Mass High Tech
Recently, a federal appeals court heard oral arguments in a patent case, the ruling in which could significantly impact Massachusetts-based academic research organizations, biotechnology companies, and pharmaceutical companies.
11 Users are viewing the Biotech Forum right now
|Steering a company in a new direction||Tue||Philip Cohen||1|
|GlaxoSmithKline faces bribery investigation in ...||Mon||Pigs three different ones||3|
|Effective Messages in Vaccine Promotion: A Rand...||Apr 11||CENSORSHIP||2|
|Lawsuits filed over Lipitor side effects (Jun '06)||Apr 9||Marilyn||843|
|Poor mental health linked to reduced life expec... (Aug '12)||Apr 8||Elise Gingrich||5|
|Divide over HIV prevention drug Truvada persists||Apr 6||juls||2|
|Apple, Pfizer, others form 'go slow' U.S. paten...||Apr 5||abc123||1|